Document Details
Form
Filing Date
Oct 15, 2026
Document Date
Oct 13, 2026
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Regeneron Pharmaceuticals Inc.
Issuer
REGENERON PHARMACEUTICALS, INC.
Filer
MURPHY ANDREW J